ANTIVIR RES 润色咨询

ANTIVIRAL RESEARCH

出版年份:1981 年文章数:1836 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:7.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=2e49555, cover=https://img.medsci.cn/images/journal/cover/2021/JHQ_202109271314159400.jpg, fullname=ANTIVIRAL RESEARCH, abbr=ANTIVIR RES, pyear=1981, frequence=Monthly, articleNumbers=1836, citedSelf2015=7.1, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.2月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0166-3542, greenSci=https://www.greensci.net/search?kw=0166-3542, scijournal=https://www.scijournal.org/impact-factor-of-ANTIVIR-RES.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.33, medsciHotlight=4.767, medsciHotlight5year=7.47674, citescore=10.6, hIndex=124, impactFactor=7.6, orgnization=Elsevier, orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.journals.elsevier.com/antiviral-research/, websiteHits=10205, guideForAuthor=null, guideForAuthorHits=8, submitWebsite=https://www.evise.com/evise/faces/pages/navigation/NavController.jspx?JRNL_ACR=AVR, submitWebsiteHits=1978, content=Antiviral Research publishes full-length original articles, short definitive papers and review articles (one per issue) pertaining to the effective control of virus infections in animals and man as well as in plants or lower organisms. Its scope encompasses: -the mechanism of natural and acquired host resistance against virus infections, including aspecific cellular resistance, interferons, cellular and humoral immunity in virus infections, chemotherapeutics which influence host resistance; -the development of new vaccines or novel forms of serotherapy against viral diseases, including virological characterization of vaccine strains or vaccine preparations; preparation and characterization of antiviral immunoglobulins; safety and efficiency assessment; field trials; -the development of new antiviral chemotherapeutics, including chemistry; in vitro activity; mechanism of action; activity in animal model systems; clinical trials., totalCites=13955, brief=ANTIVIR RES杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=病毒学" >病毒学</a></strong>”子行业的中等级别杂志, articleType=论著,综述各类型文章都接收, medsciHeat=黑红, medsciComment=ANTIVIR RES在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=2e49555'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=2144, tagName=HBV, createdHits=1), ImpactFactorTagDto(id=53598, tagName=anti-influenza, createdHits=1), ImpactFactorTagDto(id=57725, tagName=药物抗病毒, createdHits=1), ImpactFactorTagDto(id=22838, tagName=疱疹病毒, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=4.5), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.39), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.19), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=10.6)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=6.527), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=4.554), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=4.88), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.797), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.33)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=38/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Immunology and Microbiology - Virology , rank=11/66)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q1), GetImpactFactorCiteScoreGradeResponse(smallClass=VIROLOGY, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0166-3542[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=ANTIVIRAL RESEARCH[ta], article_number=135, article_number_cn=40, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
ANTIVIR RES/ANTIVIRAL RESEARCH
ISSN
0166-3542
影响指数话题
预警等级
MedSci期刊指数
4.33 (MedSci实时期刊指数) | 7.47674 (5年期刊指数)
CiteScore值
10.6
h-index
124
h5-median
暂无数据
出版社/管理机构
杂志由 Elsevier 出版或管理
出版国家/地区
Netherlands 荷兰
出版周期
Monthly
出版年份
1981
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
PHARMACOLOGY & PHARMACY Q1
VIROLOGY Q2
中科院分区
大类:医学 2区
小类:医学 2 区